Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$519M |
| 2 |
Netflix
NFLX
|
+$448M |
| 3 |
Qualcomm
QCOM
|
+$280M |
| 4 |
Microsoft
MSFT
|
+$252M |
| 5 |
Broadcom
AVGO
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$453M |
| 2 |
ExxonMobil
XOM
|
+$234M |
| 3 |
GMS
GMS Inc
GMS
|
+$217M |
| 4 |
SKX
Skechers
SKX
|
+$201M |
| 5 |
Capital One
COF
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 17.99% |
| 3 | Industrials | 12.15% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Healthcare | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Flotek Industries
FTK
$881M
| $6.21M | ﹤0.01% |
425,579
+102,136
| +32% | +$1.29M |
|
|
OKLO
2477
Oklo
OKLO
$7.27B
| $6.21M | ﹤0.01% |
+55,427
| New | +$4.34M |
|
2478
NVE Corp
NVEC
$568M
| $6.21M | ﹤0.01% |
95,112
-6,525
| -6% | -$442K |
|
2479
Simulations Plus
SLP
$371M
| $6.19M | ﹤0.01% |
410,852
-74,552
| -15% | -$1.08M |
|
2480
Arq
ARQ
$85.4M
| $6.13M | ﹤0.01% |
856,652
+81,984
| +11% | +$542K |
|
2481
Iovance Biotherapeutics
IOVA
$2.19B
| $6.13M | ﹤0.01% |
2,822,758
-105,978
| -4% | -$250K |
|
2482
Phreesia
PHR
$657M
| $6.09M | ﹤0.01% |
258,950
-15,616
| -6% | -$425K |
|
2483
Entravision Communication
EVC
$1.02B
| $6.07M | ﹤0.01% |
2,604,062
-57,785
| -2% | -$141K |
|
2484
AB InBev
BUD
$156B
| $6.07M | ﹤0.01% |
101,751
+1,160
| +1% | +$73K |
|
2485
Lexeo Therapeutics
LXEO
$351M
| $6.06M | ﹤0.01% |
912,533
+865,510
| +1,841% | +$4.19M |
|
2486
Immunovant
IMVT
$8.23B
| $6.03M | ﹤0.01% |
374,285
+137,319
| +58% | +$2.22M |
|
2487
Voyager Therapeutics
VYGR
$187M
| $5.99M | ﹤0.01% |
1,283,156
-138,026
| -10% | -$499K |
|
2488
Talkspace
TALK
$874M
| $5.97M | ﹤0.01% |
2,164,276
+394,757
| +22% | +$1.02M |
|
2489
Itaú Unibanco
ITUB
$92.3B
| $5.96M | ﹤0.01% |
837,028
+114,036
| +16% | +$753K |
|
2490
Lindblad Expeditions
LIND
$1.84B
| $5.95M | ﹤0.01% |
464,988
+31,695
| +7% | +$417K |
|
2491
Rigel Pharmaceuticals
RIGL
$692M
| $5.93M | ﹤0.01% |
209,387
+54,366
| +35% | +$1.63M |
|
|
HTT
2492
High Templar Tech Ltd
HTT
$376M
| $5.92M | ﹤0.01% |
1,384,096
-23,489
| -2% | -$94.2K |
|
2493
InfuSystem Holdings
INFU
$189M
| $5.9M | ﹤0.01% |
569,238
+4,430
| +0.8% | +$36.8K |
|
2494
Janux Therapeutics
JANX
$950M
| $5.88M | ﹤0.01% |
240,631
+101,970
| +74% | +$2.48M |
|
2495
Embotelladora Andina Series B
AKO.B
$4.65B
| $5.88M | ﹤0.01% |
248,312
-3,718
| -1% | -$88.6K |
|
2496
SITE Centers
SITC
$232M
| $5.85M | ﹤0.01% |
649,183
+8,886
| +1% | +$94.5K |
|
|
DXUV
2497
Dimensional US Vector Equity ETF
DXUV
$526M
| $5.84M | ﹤0.01% |
100,000
| – | – |
|
|
CHCT
2498
Community Healthcare Trust
CHCT
$538M
| $5.83M | ﹤0.01% |
381,072
+25,413
| +7% | +$398K |
|
2499
Escalade
ESCA
$262M
| $5.83M | ﹤0.01% |
463,461
-3,370
| -0.7% | -$43.3K |
|
2500
Bank7 Corp
BSVN
$472M
| $5.77M | ﹤0.01% |
124,643
+5,859
| +5% | +$274K |
|
Similar funds
Dimensional Fund Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Dimensional Fund Advisors held 3,356 positions worth $466B, up 7.9% from $432B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q3 2025 filing shows 84 new, 1,582 increased, 1,511 reduced and 85 closed positions. Its largest new stake was Qiagen: 1,300,037 shares worth $58.1M. The largest sale was Hess, an estimated $453M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q3 2025 buy was Qiagen: 1,300,037 shares worth $58.1M.
- Dimensional Fund Advisors added most to Chevron in Q3 2025, an estimated $519M increase.
- Dimensional Fund Advisors's biggest Q3 2025 reduction was ExxonMobil, cutting an estimated $234M.
- Dimensional Fund Advisors fully exited Hess in Q3 2025, selling an estimated $453M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $466B portfolio in Q3 2025.
- Dimensional Fund Advisors opened 84 new positions and closed 85 in Q3 2025.
- Dimensional Fund Advisors's portfolio value rose 7.9% quarter-over-quarter to $466B.
Based on Dimensional Fund Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.